ReNeuron Group plc

ReNeuron Group plcverified

RNUGF

Price:

$0.0011

Market Cap:

$47.09K

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells ...[Read more]

Industry

Biotechnology

IPO Date

2007-04-12

Stock Exchange

OTC

Ticker

RNUGF

The Enterprise Value as of December 2025 (TTM) for ReNeuron Group plc (RNUGF) is -5684907.22

According to ReNeuron Group plc’s latest financial reports and current stock price. The company's current Enterprise Value is -5684907.22. This represents a change of -276.89% compared to the average of 3.21M of the last 4 quarters.

ReNeuron Group plc (RNUGF) Historical Enterprise Value (quarterly & annually)

How has RNUGF Enterprise Value performed in the past?

The mean historical Enterprise Value of ReNeuron Group plc over the last ten years is 31.74M. The current -5684907.22 Enterprise Value has changed -1891.07% with respect to the historical average. Over the past ten years (40 quarters), RNUGF's Enterprise Value was at its highest in in the March 2016 quarter at 114.58M. The Enterprise Value was at its lowest in in the March 2023 quarter at -2561310.51.

Quarterly (TTM)
Annual

Average

31.74M

Median

22.71M

Minimum

-1563867.17

Maximum

94.51M

ReNeuron Group plc (RNUGF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ReNeuron Group plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 375.99%

Maximum Annual Enterprise Value = 94.51M

Minimum Annual Increase = -120.87%

Minimum Annual Enterprise Value = -1563867.17

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-1563867.17-120.87%
20227.49M-78.15%
202134.28M39.89%
202024.51M17.20%
201920.91M375.99%
20184.39M-94.18%
201775.51M-20.10%
201694.51M154.29%
201537.16M83.95%
201420.20M73.66%

ReNeuron Group plc (RNUGF) Average Enterprise Value

How has RNUGF Enterprise Value performed in the past?

The current Enterprise Value of ReNeuron Group plc (RNUGF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.40M

5-year avg

17.13M

10-year avg

31.74M

ReNeuron Group plc (RNUGF) Enterprise Value vs. Peers

How is RNUGF’s Enterprise Value compared to its peers?

ReNeuron Group plc’s Enterprise Value is less than Ayala Pharmaceuticals, Inc. (7.85M), less than Algernon Pharmaceuticals Inc. (2.65M), less than Appili Therapeutics Inc. (14.26M), less than Universal Ibogaine Inc. (3.95M), less than Restart Life Sciences Corp. (3.44M), less than AXIM Biotechnologies, Inc. (14.70M), less than VG Life Sciences Inc. (2.11M), less than America Great Health (4.75M), less than Regen BioPharma, Inc. (1.32M), less than Health Sciences Group, Inc. (505.72K),

Build a custom stock screener for ReNeuron Group plc (RNUGF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ReNeuron Group plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ReNeuron Group plc (RNUGF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ReNeuron Group plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ReNeuron Group plc's Enterprise Value?

What is the highest Enterprise Value for ReNeuron Group plc (RNUGF)?

What is the 3-year average Enterprise Value for ReNeuron Group plc (RNUGF)?

What is the 5-year average Enterprise Value for ReNeuron Group plc (RNUGF)?

How does the current Enterprise Value for ReNeuron Group plc (RNUGF) compare to its historical average?